Taken together, these results suggest that IGF2BP1 binds to and regulates the expression of multiple pro-oncogenic signaling pathways in ETV6::RUNX1 positive B-ALL cells. The gene discussed is RUNX1; the disease is acute lymphoblastic leukemia.